Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road
International Relation

Pakistan approves China's Sinopharm COVID-19 vaccine for emergency use

January 19, 2021


Abstract : The Drug Regulatory Authority of Pakistan (DRAP) has approved a vaccine by China's Sinopharm for emergency use amid rising cases of COVID-19 in the country.

ISLAMABAD, Jan. 19 (Xinhua) -- The Drug Regulatory Authority of Pakistan (DRAP) has approved a vaccine by China's Sinopharm for emergency use amid rising cases of COVID-19 in the country.

A handout by DRAP on its official website late Monday read that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality.

The authority said the authorization will be reviewed every quarter keeping in view further data regarding safety, efficacy and quality.

A vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca has also been given the authorization earlier, the handout said.

Chaudhry Fawad Hussain, the country's minister for science and technology, told Xinhua earlier that the Sinopharm vaccine has been approved for procurement by a cabinet committee for its safety and affordability.

Pakistan reported 1,920 new coronavirus infections and 46 deaths on Monday, bringing the total number of cases to 521,211 with 10,997 deaths. Enditem

Scan the QR code and push it to your mobile phone

Keyword: China-Pakistan COVID-19 vaccine Sinopharm

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial